We are interested in studying the biology of the human immune system and how it interacts with growing tumors in patients. We are particularly interested in understanding the tumor and host related factors underlying the transformation of preneoplastic monoclonal gammopathy to its malignant counterpart, multiple myeloma (MM). We are also studying the biology of how human dendritic cells regulate immune responses to different types of antigens. Our goal is to learn to harness the properties of the immune system to detect, prevent and treat cancer, with a particular focus on multiple myeloma. Specialized Terms: Myeloma and related plasma cell disorders; Human immune system's interaction with growing tumors in patients; Preneoplastic monoclonal gammopathy and multiple myeloma, tumor and host related factors

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811